Literature DB >> 29715080

Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds.

Sucharat Tungsukruthai1,2, Nalinrat Petpiroon3,4, Pithi Chanvorachote3,4.   

Abstract

Throughout the world, breast cancer is among the major causes of cancer-related death and is the most common cancer found in women. The development of cancer molecular knowledge has surpassed the novel concept of cancer biology and unraveled principle targets for anticancer drug developments and treatment strategies. Metastatic breast cancer cells acquire their aggressive features through several mechanisms, including augmentation of survival, proliferation, tumorigenicity, and motility-related cellular pathways. Clearly, natural product-derived compounds have since long been recognized as an important source for anticancer drugs, several of which have been shown to have promising anti-metastasis activities by suppressing key molecular features supporting such cell aggressiveness. This review provides the essential details of breast cancer, the molecular-based insights into metastasis, as well as the effects and mechanisms of potential compounds for breast cancer therapeutic approaches. As the abilities of cancer cells to invade and metastasize are addressed as the hallmarks of cancer, compounds possessing anti-metastatic effects, together with their defined molecular drug action could benefit the development of new drugs as well as treatment strategies. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; anti-metastasis compounds; metastasis; natural product; review

Mesh:

Substances:

Year:  2018        PMID: 29715080     DOI: 10.21873/anticanres.12502

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Three dimensional engineered models to study hypoxia biology in breast cancer.

Authors:  Vaishali Aggarwal; Oshin Miranda; Paul A Johnston; Shilpa Sant
Journal:  Cancer Lett       Date:  2020-06-20       Impact factor: 8.679

2.  Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK/STAT signaling pathway.

Authors:  Marwah Suliman Maashi; Mahmood Al-Mualm; Ghaidaa Raheem Lateef Al-Awsi; Maria Jade Catalan Opulencia; Moaed E Al-Gazally; Bekhzod Abdullaev; Walid Kamal Abdelbasset; Mohammad Javed Ansari; Abduladheem Turki Jalil; Fahad Alsaikhan; Mohammed Nader Shalaby; Yasser Fakri Mustafa
Journal:  Mol Biol Rep       Date:  2022-07-08       Impact factor: 2.742

3.  Wikstromol from Wikstroemia indica induces apoptosis and suppresses migration of MDA-MB-231 cells via inhibiting PI3K/Akt pathway.

Authors:  Huankai Yao; Xiuli Zhang; Nan Zhang; Jindong Li; Yan Li; Qunli Wei
Journal:  J Nat Med       Date:  2020-08-31       Impact factor: 2.343

4.  Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

Authors:  Meng Jin; Daili Gao; Rongchun Wang; Attila Sik; Kechun Liu
Journal:  Oncol Rep       Date:  2020-06-11       Impact factor: 3.906

5.  Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.

Authors:  Hong-Sheng Zhang; Zhong-Guo Zhang; Guang-Yuan Du; Hong-Liang Sun; Hui-Yun Liu; Zhen Zhou; Xiao-Meng Gou; Xi-Hao Wu; Xiao-Ying Yu; Ying-Hui Huang
Journal:  J Cell Mol Med       Date:  2019-02-26       Impact factor: 5.310

6.  Relationship between red cell distribution width and prognosis in patients with breast cancer after operation: a retrospective cohort study.

Authors:  Deshun Yao; Zhiwu Wang; Haifeng Cai; Ying Li; Baosheng Li
Journal:  Biosci Rep       Date:  2019-07-12       Impact factor: 3.840

7.  Ectodermal-neural cortex 1 as a novel biomarker predicts poor prognosis and induces metastasis in breast cancer by promoting Wnt/β-catenin pathway.

Authors:  Yuhui Zhou; Xiaojiang Tang; Ligang Niu; Yang Liu; Bin Wang; Jianjun He
Journal:  J Cell Mol Med       Date:  2020-07-03       Impact factor: 5.310

8.  Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways-In Vitro and In Vivo Studies.

Authors:  Satish Kumar Vemuri; Satyajit Halder; Rajkiran Reddy Banala; Hari Krishnreddy Rachamalla; Vijaya Madhuri Devraj; Chandra Shekar Mallarpu; Uttam Kumar Neerudu; Ravikiran Bodlapati; Sudip Mukherjee; Subbaiah Goli Peda Venkata; Gurava Reddy Annapareddy Venkata; Malarvilli Thakkumalai; Kuladip Jana
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

9.  Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.

Authors:  Jyotsana Singhal; Preeti Singhal; David Horne; Ravi Salgia; Sanjay Awasthi; Sharad S Singhal
Journal:  Cancer Lett       Date:  2018-09-15       Impact factor: 8.679

10.  Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer.

Authors:  Adam Hermawan; Herwandhani Putri; Naufa Hanif; Muthi Ikawati
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.